Futura Medical (FUM)

 

Latest News

Futura reports publication of positive MED2002 data

Futura Medical has announced the publication of positive data from its phase II clinical trial of MED2002 in erectile dysfu...

Publication of Positive MED2002 Clinical Data

RNS Number: 9126A Futura Medical PLC 04 January 2018 For immediate release 4 January 2018 Futura Medical plc ("Futura" or "the Company") Publication of Positive MED2002 Clinical Data Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the publication of positive data fr...

Director/PDMR Shareholding

RNS Number: 8847A Futura Medical PLC 03 January 2018 3 January 2018 Futura Medical plc ("Futura" or "the Company") PDMR Dealing Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology has been notified that Rachael Hawken, a person discharging managerial responsibilities ("PDMR"), has sold 10,...

Remuneration of Non-Executive Directors and TVR

RNS Number: 7603A Futura Medical PLC 02 January 2018 For immediate release 2 January 2018 Futura Medical plc ("Futura" or "the Company") Remuneration of Non-Executive Directors and Total Voting Rights Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces the issue of 37,320 new o...

All News

DateHeadlineSource
04-01-18Futura reports publication of positive MED2002 data StockMarketWire
04-01-18Publication of Positive MED2002 Clinical DataRNS
03-01-18Director/PDMR ShareholdingRNS
02-01-18Remuneration of Non-Executive Directors and TVRRNS
29-11-17Recruitment starts for PK study, says Futura StockMarketWire
29-11-17MED2002: PK Study CommencesRNS
29-11-17MED2002: Regulatory, Clinical & Commercial UpdateRNS
24-11-17Block Listing UpdateRNS
23-10-17PDMR DealingRNS
16-10-17Futura reports further positive data on MED2002StockMarketWire
16-10-17Further Positive Market Research Data for MED2002RNS
13-09-17Directors' / PDMR Dealing and Grant of OptionsRNS
12-09-17Futura net losses narrow StockMarketWire
12-09-17Interim ResultsRNS
01-09-17Notification of Major Interest in SharesRNS
23-08-17CSD500: Termination of Licensing AgreementRNS
22-08-17Notification of Half Year ResultsRNS
04-07-17Investor Presentation on MED2002RNS
14-06-17Result of AGMRNS
14-06-17Futura Medical making good progressStockMarketWire
14-06-17AGM StatementRNS
31-05-17MED2002 Regulatory UpdateRNS
31-05-17Total Voting RightsRNS
22-05-17Block Listing UpdateRNS
20-04-17Futura Medical schedules AGMStockMarketWire
20-04-17Notice of AGMRNS
04-04-17Notification of Major Interest in SharesRNS
04-04-17Notification of Major Interest in SharesRNS
23-03-17Preliminary ResultsRNS
22-03-17Licenses CSD500 in PortugalRNS
06-03-17China's weaker economic growth concerns investorsStockMarketWire
06-03-17Futura files new patent as research confirms $1bn potential StockMarketWire
06-03-17Research Confirms MED2002's US$1 Billion PotentialRNS
06-03-17MED2002 Additional Patent FilingRNS
23-01-17Futura Medical schedules FY results StockMarketWire
23-01-17Notice of Preliminary ResultsRNS
18-01-17Director's dealingsRNS
13-01-17Director / PDMR Dealing and Grant of OptionsRNS
12-01-17Director Deals - Futura Medical PLC (FUM)StockMarketWire
12-01-17Director Deals - Futura Medical PLC (FUM)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:FUM Editorial
  • Regulatory news feed for LSE:FUM Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account